3 माह से 16 वर्ष की आयु के बच्चों में गैर-गंभीर फुफ्फुसीय टीबी का उपचार

References

1. In children and adolescents between 3 months and 16 years of age with non-severe TB (without suspicion or evidence of MDR/RR-TB), a 4-month treatment regimen (2HRZ(E)/2HR) should be used.
2. All patients weighing more than 3 kg and aged between 3 months and 16 years, with non-severe TB based on the definition presented in Box 2.1, should be treated with the 4-month regimen 2HRZ(E)/2HR, with or without ethambutol.
3. Children and adolescents aged between 3 months and 16 years with non-severe DS-TB should receive the 4-month regimen 2HRZ(E)/2HR, which comprises isoniazid, rifampicin and pyrazinamide, with or without ethambutol, for 2 months followed by isoniazid and rifampicin for 2 months.
4. In addition, it is recommended that ethambutol be added to the 4-month regimen for the first 2 months in settings with a high background prevalence of isoniazid resistance or HIV infection.
5. TB symptoms are expected to have resolved within one month of treatment initiation.
6. The child or adolescent is expected to be completely well, including a normal nutritional status (similar to before they developed symptoms of TB) after 4 months of treatment.
7. Symptomatic improvement and weight gain are the most valuable markers of treatment success or failure.